Aditxt Inc. named Jeffrey M. Busch, former CEO of NYSE-listed Global Medical REIT, as interim CEO effective May 31, 2026, while founder Amro Albanna resigned from all company positions. Busch will lead the company's commercialization strategy for its Ignite Proteomics precision oncology diagnostics platform while continuing as Ignite's CEO.